Treatment satisfaction, safety and effectiveness of adding methotrexate to adalimumab in patients with psoriasis responding suboptimally to adalimumab in a real-world setting

Br J Dermatol. 2022 Apr;186(4):726-728. doi: 10.1111/bjd.20885. Epub 2022 Jan 20.

K A Papp^{1

2}, M J Gooderham^{1

3

4}, L E Albrecht^{1

5

6}, M-A Raymond⁷, C W Lynde^{1

8}

¹ Probity Medical Research, Waterloo, ON, Canada.
² K. Papp Clinical Research, Waterloo, ON, Canada.
³ SKiN Centre for Dermatology, Peterborough, ON, Canada.
⁴ Queen's University, Kingston, ON, Canada.
⁵ Enverus Medical Research, Surrey, BC, Canada.
⁶ Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada.
⁷ Former employee of AbbVie Corporation, Montreal, QC, Canada.
⁸ University of Toronto, Toronto, ON, Canada.

Abstract